HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pituitary adenylyl cyclase-activating peptides and alpha-amidation in olfactory neurogenesis and neuronal survival in vitro.

Abstract
We investigated the role of amidated neuropeptides, and specifically pituitary adenylyl cyclase-activating polypeptide (PACAP), in olfactory neurogenesis and olfactory receptor neuronal survival. Using both immunohistochemistry and in situ hybridization, we find that both peptidylglycine alpha-amidating monooxygenase (PAM), the enzyme responsible for amidation and therefore activation of all amidated neuropeptides, and amidated PACAP are expressed in developing and adult olfactory epithelium. Amidated PACAP is highly expressed in proliferative basal cells and in immature olfactory neurons. The PACAP-specific receptor PAC(1) receptor is also expressed in this population, establishing that these cells can be PACAP responsive. Experiments were conducted to determine whether amidated neuropeptides, such as PACAP38, might function in olfactory neurogenesis and neuronal survival. Addition of PACAP38 to olfactory cultures increased the number of neurons to >250% of control and stimulated neuronal proliferation and survival. In primary olfactory cultures, pharmacologically decreased PAM activity, as well as neutralization of PACAP38, caused neuron-specific loss that was reversed by PACAP38. Mottled (Brindled) mice, which lack a functional ATP7A copper transporter and serve as a model for Menkes disease, provided an in vivo partial loss-of-function PAM knock-out. These mice had decreased amidated PACAP production and concomitant decreased numbers of olfactory receptor neurons. These data establish amidated peptides and specifically PACAP as having important roles in proliferation in the olfactory system and suggest that a similar function exists in vivo.
AuthorsD E Hansel, V May, B A Eipper, G V Ronnett
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 21 Issue 13 Pg. 4625-36 (Jul 01 2001) ISSN: 1529-2401 [Electronic] United States
PMID11425890 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adcyap1 protein, mouse
  • Adcyap1 protein, rat
  • Amides
  • Atp7a protein, mouse
  • Carrier Proteins
  • Cation Transport Proteins
  • Multienzyme Complexes
  • Neuropeptides
  • Peptide Fragments
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Hormone
  • Recombinant Fusion Proteins
  • pituitary adenylate-cyclase-activating-peptide (6-38)
  • Ditiocarb
  • Mixed Function Oxygenases
  • peptidylglycine monooxygenase
  • Adenosine Triphosphatases
  • Atp7a protein, rat
  • Copper-Transporting ATPases
Topics
  • Adenosine Triphosphatases (deficiency, genetics)
  • Aging (metabolism)
  • Amides (metabolism)
  • Animals
  • Carrier Proteins (genetics)
  • Cation Transport Proteins
  • Cell Count
  • Cell Division (drug effects)
  • Cell Survival (drug effects)
  • Copper-Transporting ATPases
  • Ditiocarb (pharmacology)
  • Dose-Response Relationship, Drug
  • Female
  • In Situ Hybridization
  • Male
  • Menkes Kinky Hair Syndrome (enzymology, genetics)
  • Mice
  • Mice, Inbred C57BL
  • Mixed Function Oxygenases (antagonists & inhibitors, metabolism)
  • Multienzyme Complexes
  • Neuropeptides (antagonists & inhibitors, genetics, metabolism, pharmacology)
  • Olfactory Mucosa (embryology, enzymology, innervation)
  • Olfactory Receptor Neurons (cytology, drug effects, metabolism)
  • Peptide Fragments (pharmacology)
  • Pituitary Adenylate Cyclase-Activating Polypeptide
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
  • Receptors, Pituitary Hormone (metabolism)
  • Recombinant Fusion Proteins
  • Signal Transduction (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: